Implementation of a pharmaceutical care program for patients with hepatitis C treated with new direct-action antivirals

Sevilla, María A.; Úbeda, Marta Gallego; Benito, Miriam Heredia; García-Cabrera, Emilio; García, Beatriz Monje; Pozo, María Tovar; Cepeda, L. Delgado Téllez de; Peinado, Irene Iglesias

doi:10.1007/s11096-019-00809-3

Cited by 4 publications

(4 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similarly, it seems that this is the first study to be performed at the payer level in a developing country that assessed the economic cost and clinical value of a pharmaceutical care program for chronically ill patients. 14,11,15 Studies that have previously described the impact of pharmaceutical care were limited to hospitals and community pharmacies. [16][17][18] Yet, we believe that this research is very important because it displays and builds the concept in view of a different field, which is the health insurance system.…”

Section: Discussionmentioning

confidence: 99%

“…No studies examining the association between such pharmaceutical care programs for HCV patients using new medications and health-related outcomes and cost were available from a payer prospective. 10,11 Therefore, the objectives of this study were to: (1) describe a unique HCV pharmaceutical care model program provided to HCV patients through private insurance and (2) assess the impact of the program on clinical outcomes, patient satisfaction, and overall cost at the level of health insurance.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level

Almahdi¹,

Hashim

Albaba³

et al. 2020

Value in Health Regional Issues

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level

Almahdi¹,

Hashim

Albaba³

et al. 2020

Value in Health Regional Issues

View full text Add to dashboard Cite

“…The frequency of patients with type 3 genotype was slightly higher than HCV genotype 1 in this sample. However, worldwide HCV virus genotype 1 has been prevalent over genotype 3 (Petruzziello, Marigliano, Loquercio, Cozzolino, & Cacciapuoti, 2016;Campos Fernández de Sevilla, et al, 2019a, , Slevin et al, 2019Gomes et al, 2020) as well as in the southern region of Brazil (Campiotto, et al, 2005, Lampe et al, 2013.…”

Section: Clinical Featuresmentioning

confidence: 99%

Hepatitis C: sociodemographic and clinical profile of patients treated with direct-acting antivirals in a pharmaceutical office

Pegoraro,

Folador,

Bertolini

et al. 2023

Acta Sci. Health Sci.

View full text Add to dashboard Cite

To report the sociodemographic and clinical profile of patients treated with direct-action antivirals (DAAs). Patients infected with hepatitis C virus in current treatment were followed up in a pharmaceutical office. Sociodemographic, clinical and medicines uses characteristics were obtained. A total of 62 patients were enrolled, with a higher proportion of men, aged between 40 and 69 years, low schooling, and workers. Were predominant the HCV virus genotype 1 (45.2%) and 3 (48.4%), and 19.4% were cirrhotic. Of the referred comorbidities, stood out those diseases related to the cardiovascular system (19.8%), psychiatric disorders (17.6%), endocrine and metabolic disorders (14.5%). Co-infections represented 5.2%, and were distributed between acute hepatitis A (1.0%), chronic viral hepatitis B (2.1%), and HIV (2.1%). Previous or current use of licit / illicit substances was reported by 33.9% of patients. A significant difference was identified in the youngest age group (25 to 39 years, p = 0.02), with a lower average viral load compared to the other age groups. The pharmacotherapeutic follow-up carried out in the period resulted in 157 pharmaceutical consultations. Patients with hepatitis C using DDAs were mostly men, aged between 40 and 69 years. Type 3 HCV genotype was most frequently identified. The presence of cirrhosis and other comorbidities serves as an alert for health professionals in the implementation of public health policies.

show abstract

“…[5][6][7] Moreover, the World Health Organization (WHO) and the International Pharmaceutical Federation have indicated the importance of changing the traditional role of pharmacists from product-oriented towards a patient-centered practice by considering the high demand of health issues with myriad range of chronic diseases and poor adherence to prescribed medicines. 8 Since then, many articles have highlighted the outcomes of PC implementation in the health care system throughout the world, [9][10][11][12][13][14][15] even during the recent COVID-19 pandemic. 16 For instance, preventing medication errors, reducing the incidence of adverse drug reaction, and saving medical costs are the main benefits of PC implementation reported in the aforementioned studies.…”

Section: Introductionmentioning

confidence: 99%

Patients Satisfaction with Pharmaceutical Care and Associated Factors in the Southwestern Ethiopia

Hasen

Negeso

2021

PPA

View full text Add to dashboard Cite

Background An evaluation of patient satisfaction with service provided in the health care system has been globally recognized as the measure of health care service quality. However, there is a lack of research findings that indicate patient satisfaction with newly implemented patient-oriented pharmaceutical care (PC) service provided by clinical pharmacists in Ethiopia. Therefore, the current study is aimed to determine the level of patient satisfaction and associated factors with PC service provided by clinical pharmacists in the Southwestern Ethiopia. Methodology A facility-based cross-sectional study design was employed among patients admitted to Medical wards in Jimma University Medical Center (JUMC) (n=219) from May to June 2021. The pretested interviewer-administered questionnaire containing structured questions on a 5-point Likert scale was appropriately completed and returned for statistical analysis. For the analysis of data, Statistical Package for Social Sciences (SPSS) was used. The associations between status of patient satisfaction and predictors were determined at 5% (p<0.05) level of significance by employing multivariate logistic regression. Results The current study revealed that more than half (56%) of the respondents were satisfied with clinical pharmacy service. From 30% of drug therapy problems (DTPs) reported, non-adherence was the most prevalent (11.4%), while the dose being too low and adverse effects (0.9%) were the least reported. Moreover, the assignment particular clinical pharmacist (AOR: 2.091, 95% CI: 1.028, 4.255), previous admission (AOR: 0.459, 95% CI: 0.244, 0.86), number of medications taken per day (AOR: 1.929, 95% CI: 1.996, 3.739) and length of hospital stay (AOR: 2.236, 95% CI: 1.124, 4.446) were significantly associated with patient satisfaction. Conclusion The present study revealed that patient satisfaction towards PC was low. Lack of specific clinical pharmacist assignment, previous history of admission, number of medications taken per day and length of hospital stay are revealed as the major factors affecting the level of satisfaction. In addition, current findings implicate that clinical pharmacist collaboration with a multidisciplinary team is essential to increase patient satisfaction.

show abstract

Implementation of a pharmaceutical care program for patients with hepatitis C treated with new direct-action antivirals

Cited by 4 publications

References 15 publications

The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level

The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level

Hepatitis C: sociodemographic and clinical profile of patients treated with direct-acting antivirals in a pharmaceutical office

Patients Satisfaction with Pharmaceutical Care and Associated Factors in the Southwestern Ethiopia

Contact Info

Product

Resources

About